| Final results of the 94–01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced … F Denis, P Garaud, E Bardet, M Alfonsi, C Sire, T Germain, P Bergerot, ... Journal of clinical oncology 22 (1), 69-76, 2004 | 1075 | 2004 |
| Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study MC Garassino, BC Cho, JH Kim, J Mazières, J Vansteenkiste, H Lena, ... The Lancet Oncology 19 (4), 521-536, 2018 | 560 | 2018 |
| Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients F Denis, C Lethrosne, N Pourel, O Molinier, Y Pointreau, J Domont, ... JNCI: Journal of the National Cancer Institute 109 (9), djx029, 2017 | 472 | 2017 |
| Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer F Denis, E Basch, AL Septans, J Bennouna, T Urban, AC Dueck, ... Jama 321 (3), 306-307, 2019 | 463 | 2019 |
| Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT … F Denis, P Garaud, E Bardet, M Alfonsi, C Sire, T Germain, P Bergerot, ... International Journal of Radiation Oncology* Biology* Physics 55 (1), 93-98, 2003 | 311 | 2003 |
| The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline M Di Maio, E Basch, F Denis, LJ Fallowfield, PA Ganz, D Howell, ... Annals of Oncology 33 (9), 878-892, 2022 | 205 | 2022 |
| 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial X Pivot, G Romieu, M Debled, JY Pierga, P Kerbrat, T Bachelot, ... The Lancet 393 (10191), 2591-2598, 2019 | 136 | 2019 |
| Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer F Denis, AV Desbiez-Bourcier, C Chapiron, F Arbion, G Body, ... European Journal of Surgical Oncology (EJSO) 30 (10), 1069-1076, 2004 | 134 | 2004 |
| What can be learned from a chaotic cancer model? C Letellier, F Denis, LA Aguirre Journal of theoretical biology 322, 7-16, 2013 | 126 | 2013 |
| Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization S Colas, K Mahéo, F Denis, C Goupille, C Hoinard, P Champeroux, ... Clinical cancer research 12 (19), 5879-5886, 2006 | 121 | 2006 |
| Improving survival in patients treated for a lung cancer using self-evaluated symptoms reported through a web application F Denis, S Yossi, AL Septans, A Charron, E Voog, O Dupuis, G Ganem, ... American journal of clinical oncology 40 (5), 464-469, 2017 | 114 | 2017 |
| Cost-effectiveness of web-based patient-reported outcome surveillance in patients with lung cancer T Lizée, E Basch, P Trémolières, E Voog, J Domont, G Peyraga, T Urban, ... Journal of Thoracic Oncology 14 (6), 1012-1020, 2019 | 104 | 2019 |
| Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid S Colas, L Paon, F Denis, M Prat, P Louisot, C Hoinard, O Le Floch, ... International journal of cancer 109 (3), 449-454, 2004 | 94 | 2004 |
| Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by 18F-misonidazole PET/CT in patients with non–small cell lung carcinoma (RTEP5 study) P Vera, S Thureau, P Chaumet-Riffaud, R Modzelewski, P Bohn, ... Journal of Nuclear Medicine 58 (7), 1045-1053, 2017 | 90 | 2017 |
| Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up F Denis, L Viger, A Charron, E Voog, O Dupuis, Y Pointreau, C Letellier Supportive Care in Cancer 22, 1467-1473, 2014 | 81 | 2014 |
| How tumor growth can be influenced by delayed interactions between cancer cells and the microenvironment? D Ghosh, S Khajanchi, S Mangiarotti, F Denis, SK Dana, C Letellier BioSystems 158, 17-30, 2017 | 79 | 2017 |
| Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer E Voog, L Campion, P Du Rusquec, H Bourgeois, J Domont, F Denis, ... Supportive Care in Cancer 26, 81-89, 2018 | 73 | 2018 |
| OLIGOPELVIS GETUG P07, a multicenter phase II trial of combined high-dose salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses in prostate cancer S Supiot, L Vaugier, D Pasquier, X Buthaud, N Magné, D Peiffert, ... European Urology 80 (4), 405-414, 2021 | 55 | 2021 |
| Early variation of FDG-PET radiomics features in NSCLC is related to overall survival-the “delta radiomics” concept S Carvalho, RTH Leijenaar, EGC Troost, W Van Elmpt, JP Muratet, ... Radiother Oncol 118 (suppl 1), S20-S21, 2016 | 54 | 2016 |
| Detecting lung cancer relapse using self-evaluation forms weekly filled at home: the sentinel follow-up F Denis, L Viger, A Charron, E Voog, C Letellier Supportive Care in Cancer 22, 79-85, 2014 | 52 | 2014 |
